ArticlemHealth2017
Community-based field implementation scenarios of a short message service reporting tool for lymphatic filariasis case estimates in Africa and Asia.
Article in mHealth, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mobile Health Strategies to Tackle Skin Neglected Tropical Diseases With Recommendations From Innovative Experiences: Systematic Review.JMIR mHealth and uHealth · 2020Pooled it
- Patient perspectives and barriers to effective home-based care in lymphatic filariasis: A mixed methods study from Puducherry, India.PLoS neglected tropical diseases · 2026Article
- Elimination of lymphatic filariasis as a public health problem in Malawi.PLoS neglected tropical diseases · 2024Article
- Methods and Approaches for Buruli Ulcer Surveillance in Africa: Lessons Learnt and Future Directions.Methods in molecular biology (Clifton, N.J.) · 2022Review
- The potential use of digital health technologies in the African context: a systematic review of evidence from Ethiopia.NPJ digital medicine · 2021Review
- Exploring determinants of hydrocele surgery coverage related to Lymphatic Filariasis in Nepal: An implementation research study.PloS one · 2021Article
- Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.International health · 2020Article
- Developing the first national database and map of lymphatic filariasis clinical cases in Bangladesh: Another step closer to the elimination goals.PLoS neglected tropical diseases · 2019Article
- Mapping and modelling the impact of mass drug adminstration on filariasis prevalence in Myanmar.Infectious diseases of poverty · 2018Article
- Article
- Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system.PLoS neglected tropical diseases · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymphatic filariasis (LF) is a neglected tropical disease (NTD) targeted for global elimination by 2020. Currently there is considerable international effort to scale-up morbidity management activities in endemic countries, however there remains a need for rapid, cost-effective methods and adaptable tools for obtaining estimates of people presenting with clinical manifestations of LF, namely lymphoedema and hydrocele. The mHealth tool '
methodsA checklist of five key factors and sub-questions was used to determine and define specific community-based field implementation scenarios for using the
resultsBased on experiences in Bangladesh, Ethiopia, Malawi, Nepal and Tanzania, four implementation scenarios were identified as suitable for using the
conclusionsA decision-making framework built from the key factors and questions, and the resulting four implementation scenarios is proposed as a means of using the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.